from the speedily evolving field of cancer therapeutics, comprehension the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is important for creating productive treatments. One of the more promising approaches is the use of in vitro bystander result assays, which play a pivotal function in boosting therapeutic efficacy. These assays, supplie